BHST Key Statistics, Chart & Performance
The current stock price of BHST is 5.5 USD. In the past month the price decreased by -17.42%. In the past year, price decreased by -12.56%.
BHST Latest News, Press Relases and Analysis
BHST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 62.14 | 37.62B | ||
| KVUE | KENVUE INC | 16.12 | 33.05B | ||
| ELF | ELF BEAUTY INC | 25.49 | 4.68B | ||
| BRBR | BELLRING BRANDS INC | 14.25 | 3.70B | ||
| COTY | COTY INC-CL A | 17.21 | 2.86B | ||
| IPAR | INTERPARFUMS INC | 15.94 | 2.68B | ||
| OLPX | OLAPLEX HOLDINGS INC | 17.88 | 954.54M | ||
| EPC | EDGEWELL PERSONAL CARE CO | 6.99 | 825.13M | ||
| BNKK | BONK INC | N/A | 686.28M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.62 | 512.36M | ||
| NATR | NATURES SUNSHINE PRODS INC | 23.81 | 391.65M | ||
| USNA | USANA HEALTH SCIENCES INC | 10.37 | 371.63M |
Related stock screener links
About BHST
Company Profile
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Company Info
BIOHARVEST SCIENCES INC
1140 - 625 Howe Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16046221186
BIOHARVEST SCIENCES INC / BHST FAQ
Can you describe the business of BIOHARVEST SCIENCES INC?
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
What is the current price of BHST stock?
The current stock price of BHST is 5.5 USD. The price increased by 5.77% in the last trading session.
What is the dividend status of BIOHARVEST SCIENCES INC?
BHST does not pay a dividend.
How is the ChartMill rating for BIOHARVEST SCIENCES INC?
BHST has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does BIOHARVEST SCIENCES INC belong to?
BIOHARVEST SCIENCES INC (BHST) operates in the Consumer Staples sector and the Personal Care Products industry.
Who owns BIOHARVEST SCIENCES INC?
You can find the ownership structure of BIOHARVEST SCIENCES INC (BHST) on the Ownership tab.
BHST Technical Analysis
BHST Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BHST. Both the profitability and financial health of BHST have multiple concerns.
BHST Financial Highlights
Over the last trailing twelve months BHST reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -734.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.58% | ||
| ROE | -415.37% | ||
| Debt/Equity | 2.58 |
BHST Forecast & Estimates
For the next year, analysts expect an EPS growth of -4% and a revenue growth 161.11% for BHST